(Q46591845)
Statements
Docetaxel, with or without estramustine phosphate, as first-line chemotherapy for hormone-refractory prostate cancer: results of a multicentre, randomized phase II trial (English)
Teodoro Sava
Evi Comploj
Annamaria Fariello
Fable Zustovich
Romana Segati
Cosimo Sacco
Francesco Valduga
Gianluigi Cetto
Enzo Galligioni